Regulatory Consulting

  •  IND & IDE preparation, filing and maintenance
  • Pre-IND Meetings
  • Device pre sub meetings
  • End of Phase II meetings
  • Program design
  • Study design
  • CRO selection
  • Response to FDA queries on drugs and devices including successful resolution of issues